Cargando…

Warfarin prescription and administration: reducing the delay, improving the safety

Warfarin is frequently administered to hospital patients. The prescription and administration of this medication are particularly susceptible to error. Factors contributing to this include the narrow therapeutic index, patient-specific target range, and the need for regular INR monitoring. NICE guid...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyar, Rebecca, Hall, Simon, McIntyre, Bethannie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: British Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645946/
https://www.ncbi.nlm.nih.gov/pubmed/26734375
http://dx.doi.org/10.1136/bmjquality.u204509.w1983
_version_ 1782400900571070464
author Dyar, Rebecca
Hall, Simon
McIntyre, Bethannie
author_facet Dyar, Rebecca
Hall, Simon
McIntyre, Bethannie
author_sort Dyar, Rebecca
collection PubMed
description Warfarin is frequently administered to hospital patients. The prescription and administration of this medication are particularly susceptible to error. Factors contributing to this include the narrow therapeutic index, patient-specific target range, and the need for regular INR monitoring. NICE guidelines state that warfarin should be given at the same time every day and the Bristol Royal Infirmary guidelines are warfarin to be given at 14:00. The 14:00 dosing ensures standardisation of administration; poor adherence to this recommendation may cause patient harm. We noticed that many warfarin doses were often given outside of maximal staffing hours and it was often left to the on call doctor to prescribe warfarin at erratic and inconsistent times. Our primary aim was to reduce the number of adverse outcomes associated with warfarin prescription and administration. We targeted two system measures: the proportion of warfarin administrations occurring within an hour of the 14:00 prescription and the proportion of INR results outside target range. We employed the model for improvement and carried out our project across seven acute medical wards. Baseline data showed that only 24% of doses were being given within an hour of the recommended time and 64% of doses were being given after 17:00 during minimal staffing hours. We successfully introduced a warfarin box within our trust which demonstrated an improvement in warfarin administration from 24% of patients receiving their warfarin within an hour of 14:00 to 49% and this was subsequently associated with a reduction in INRs above target range (23% to 9%).
format Online
Article
Text
id pubmed-4645946
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher British Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46459462016-01-05 Warfarin prescription and administration: reducing the delay, improving the safety Dyar, Rebecca Hall, Simon McIntyre, Bethannie BMJ Qual Improv Rep BMJ Quality Improvement Programme Warfarin is frequently administered to hospital patients. The prescription and administration of this medication are particularly susceptible to error. Factors contributing to this include the narrow therapeutic index, patient-specific target range, and the need for regular INR monitoring. NICE guidelines state that warfarin should be given at the same time every day and the Bristol Royal Infirmary guidelines are warfarin to be given at 14:00. The 14:00 dosing ensures standardisation of administration; poor adherence to this recommendation may cause patient harm. We noticed that many warfarin doses were often given outside of maximal staffing hours and it was often left to the on call doctor to prescribe warfarin at erratic and inconsistent times. Our primary aim was to reduce the number of adverse outcomes associated with warfarin prescription and administration. We targeted two system measures: the proportion of warfarin administrations occurring within an hour of the 14:00 prescription and the proportion of INR results outside target range. We employed the model for improvement and carried out our project across seven acute medical wards. Baseline data showed that only 24% of doses were being given within an hour of the recommended time and 64% of doses were being given after 17:00 during minimal staffing hours. We successfully introduced a warfarin box within our trust which demonstrated an improvement in warfarin administration from 24% of patients receiving their warfarin within an hour of 14:00 to 49% and this was subsequently associated with a reduction in INRs above target range (23% to 9%). British Publishing Group 2015-01-14 /pmc/articles/PMC4645946/ /pubmed/26734375 http://dx.doi.org/10.1136/bmjquality.u204509.w1983 Text en © 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/http://creativecommons.org/licenses/by-nc/2.0/legalcode
spellingShingle BMJ Quality Improvement Programme
Dyar, Rebecca
Hall, Simon
McIntyre, Bethannie
Warfarin prescription and administration: reducing the delay, improving the safety
title Warfarin prescription and administration: reducing the delay, improving the safety
title_full Warfarin prescription and administration: reducing the delay, improving the safety
title_fullStr Warfarin prescription and administration: reducing the delay, improving the safety
title_full_unstemmed Warfarin prescription and administration: reducing the delay, improving the safety
title_short Warfarin prescription and administration: reducing the delay, improving the safety
title_sort warfarin prescription and administration: reducing the delay, improving the safety
topic BMJ Quality Improvement Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645946/
https://www.ncbi.nlm.nih.gov/pubmed/26734375
http://dx.doi.org/10.1136/bmjquality.u204509.w1983
work_keys_str_mv AT dyarrebecca warfarinprescriptionandadministrationreducingthedelayimprovingthesafety
AT hallsimon warfarinprescriptionandadministrationreducingthedelayimprovingthesafety
AT mcintyrebethannie warfarinprescriptionandadministrationreducingthedelayimprovingthesafety